Table 1.

Patient characteristics in the platinum rechallenge group (n = 20)

Age, years	65 (52–84)
Gender
Male/Female	17/3
Performance status at the relapse
0	7
1	11
2	0
3	2
Disease extent at the initial diagnosis
Limited disease	11
Extended disease	9
First-line therapy
Chemoradiotherapy	9
Chemotherapy	11
First-line regimen
Carboplatin and etoposide	14
Cisplatin and etoposide	5
Cisplatin and irinotecan	1
Recurrence-free intervals, (days	115 (91–404)